Back in May veteran reliever Guillermo Mota was suspended 100 games for his second positive performance enhancing drug test and today the right-hander rejoined the Giants’ active roster after serving his punishment.
At the time Mota claimed that his positive test for Clenbuterol was the result of taking a children’s cough medicine, which his agent called “severe and unfair and does not reflect the intention of the Joint Drug Prevention and Treatment Program.”
MLB did not deny that Mota’s story was plausible, yet the punishment stood and he sat out 100 games without pay. Now the 39-year-old returns to a team that just lost Melky Cabrera to a 50-game suspension and will give the Giants some middle relief innings down the stretch.
The Cubs announced on Tuesday evening that the club signed pitcher Drew Smyly to a two-year contract. Ken Rosenthal of The Athletic reports the contract is for $10 million total and allows Smyly to earn another $7 million with performance bonuses. Smyly was non-tendered by the Mariners at the beginning of the month and became a free agent.
Smyly, 28, underwent season-ending Tommy John surgery in late June. He’s expected to miss, at minimum, the first half of the 2018 season. The Cubs are hoping he can contribute to a playoff push in the latter half of the season as well as in 2019.
Smyly didn’t pitch at all in 2017. When he was healthy the season prior, he made 30 starts for the Rays and put up a 4.88 ERA and a 167/49 K/BB ratio in 175 1/3 innings.